Anti-PMEL17 antibodies and immunoconjugates
US10196454B2 · kind B2 · utility
1Cited by
119References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2017 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | Mar 27, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/77
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides anti-PMEL17 antibodies and immunoconjugates and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.